Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Jash, A. Bandyopadhyay, P. Roy, K. Saha, D. Jash (Kolkata, India). Usefulness of induced sputum eosinophil count to assess severity and treatment outcome in asthma patients. Eur Respir J 2013; 42: Suppl. 57, 833

Member's Comments

No comment yet.

Related content which might interest you: Relationship of blood eosinophil count to exacerbations in asthma patients with a COPD diagnosis Source: International Congress 2015 – Epidemiological studies of asthma and allergy Year: 2015 Clinical-functional and inflammatory evolution after one year of tracking in patients with asthma according to induced sputum cellularity Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma Source: Annual Congress 2013 –Asthma Year: 2013 Effect of baseline eosinophil count on response to CYT003-QbG10 in patients with persistent allergic asthma Source: Annual Congress 2013 –Studies of asthma in man Year: 2013 Using induced sputum cell counts to guide management of difficult-to-treat asthmatics Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 A new observer independent method to assess therapy response in children with severe asthma based on daily lung function Source: Annual Congress 2013 –Uncontrolled and severe asthma in children Year: 2013 Comparison of clinical features of severe persistent asthma and refractory asthma Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 Patients’ adherence to chronic treatment of pulmonary diseases Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 LATE-BREAKING ABSTRACT: Anti-interleukin-5 in severe asthma: Blood eosinophilia predicts lung function improvement Source: Annual Congress 2013 –Origins and diagnosis of asthma Year: 2013 Clinical, functional and inflammatory characteristics in patients with paucigranulocytic asthma Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 The influence of bronchial asthma as a comorbidity of COPD on the COPD assessment test (CAT) Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 The usefulness of FeNO and the mannitol test in detecting airway eosinophilia in asthma patients with uncontrolled symptoms Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 A treatment algorithm adjusting oral corticosteroid using blood eosinophils reduces exacerbations and improves asthma control, in difficult asthmatics Source: International Congress 2016 – Systemic biomarkers Year: 2016 Are acute exacerbation blood eosinophil numbers associated with clinical pattern of preschool wheeze? Source: International Congress 2015 – More paediatric asthma and allergy Year: 2015 Long-term efficacy of omalizumab (OMA) for patients with severe allergic asthma (SAA). Clinical assessment and relationship to serum IgE concentrations Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Asthma control, symptoms and exacerbations across treatment levels in patients with asthma Source: Annual Congress 2013 –Management of respiratory diseases in primary care Year: 2013 Blood eosinophil count as a predictor of obstructive airway disease (OAD) in a high parasite burden setting Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Assessment of serum magnesium level in patients with bronchial asthma Source: International Congress 2016 – Systemic biomarkers Year: 2016